Resection of positive tissue on methionine-PET is associated with improved survival in glioblastomas.
11C-methionine
extent of resection
glioblastoma
positron emission tomography
survival
Journal
Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837
Informations de publication
Date de publication:
16 Oct 2023
16 Oct 2023
Historique:
revised:
06
10
2023
received:
13
06
2023
accepted:
10
10
2023
medline:
17
10
2023
pubmed:
17
10
2023
entrez:
17
10
2023
Statut:
aheadofprint
Résumé
The volume of excised tumor in contrast-enhanced areas evaluated via magnetic resonance imaging is known to have a strong influence on the survival of patients with glioblastoma (GBM). In this study, we investigated the effect of tumor resection on the survival of patients with GBM in the A total of 26 patients (median age, 69 years; 15 males) who had undergone tumor resection and MET-PET before and after surgery, after being newly diagnosed with GBM, were included in the study. MET-PET before and after tumor resection were compared. The association between the decrease in the maximum standardized uptake value (SUV) of the tumor divided by the normal cortical mean SUV (%; ΔT/N), the MET extent of resection (MET-EOR) from the % reduction in the MET accumulation area (%), and residual MET accumulation area (in cm ΔT/N were positively associated with survival (hazard ratio [HR], 0.98 [95% confidence interval (CI), 0.97-0.99], p = .02). MET-RTV revealed a negative association with survival (HR, 1.02 [95% CI, 1.01-1.04], p = .04). Additionally, MET-EOR showed a strong trend with survival (HR, 0.99 [95% CI, 0.97-1.01], p = .06). Surgical resection of MET-accumulated areas in GBM significantly prolongs the survival of patients with GBM. However, a prospective large-scale multicenter study is needed to confirm our findings.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
The volume of excised tumor in contrast-enhanced areas evaluated via magnetic resonance imaging is known to have a strong influence on the survival of patients with glioblastoma (GBM). In this study, we investigated the effect of tumor resection on the survival of patients with GBM in the
METHODS
METHODS
A total of 26 patients (median age, 69 years; 15 males) who had undergone tumor resection and MET-PET before and after surgery, after being newly diagnosed with GBM, were included in the study. MET-PET before and after tumor resection were compared. The association between the decrease in the maximum standardized uptake value (SUV) of the tumor divided by the normal cortical mean SUV (%; ΔT/N), the MET extent of resection (MET-EOR) from the % reduction in the MET accumulation area (%), and residual MET accumulation area (in cm
RESULTS
RESULTS
ΔT/N were positively associated with survival (hazard ratio [HR], 0.98 [95% confidence interval (CI), 0.97-0.99], p = .02). MET-RTV revealed a negative association with survival (HR, 1.02 [95% CI, 1.01-1.04], p = .04). Additionally, MET-EOR showed a strong trend with survival (HR, 0.99 [95% CI, 0.97-1.01], p = .06).
CONCLUSIONS
CONCLUSIONS
Surgical resection of MET-accumulated areas in GBM significantly prolongs the survival of patients with GBM. However, a prospective large-scale multicenter study is needed to confirm our findings.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e3291Informations de copyright
© 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Références
Baig Mirza, A., Christodoulides, I., Lavrador, J. P., Giamouriadis, A., Vastani, A., Boardman, T., Ahmed, R., Norman, I., Murphy, C., Devi, S., Vergani, F., Gullan, R., Bhangoo, R., & Ashkan, K. (2021). 5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma-A comparative cohort study of 343 patients. Neuro-Oncology Advances, 3, vdab047.
Cao, C., Jin, Z., Shi, X., Zhang, Z., Xiao, A., Yang, J., Ji, N., Tian, J., & Hu, Z. (2022). First clinical investigation of near-infrared window IIa/IIb fluorescence imaging for precise surgical resection of gliomas. IEEE Transactions on Bio-Medical Engineering, 69, 2404-2413. https://doi.org/10.1109/TBME.2022.3143859
Certo, F., Altieri, R., Maione, M., Schonauer, C., Sortino, G., Fiumanò, G., Tirrò, E., Massimino, M., Broggi, G., Vigneri, P., Magro, G., Visocchi, M., & Barbagallo, G. M. V. (2021). FLAIRectomy in supramarginal resection of glioblastoma correlates with clinical outcome and survival analysis: A prospective, single institution, case series. Operative Neurosurgery, 20, 151-163. https://doi.org/10.1093/ons/opaa293
Chaichana, K. L., Jusue-Torres, I., Navarro-Ramirez, R., Raza, S. M., Pascual-Gallego, M., Ibrahim, A., Hernandez-Hermann, M., Gomez, L., Ye, X., Weingart, J. D., Olivi, A., Blakeley, J., Gallia, G. L., Lim, M., Brem, H., & Quinones-Hinojosa, A. (2014). Establishing percentresection and residual volume thresholds affecting survival and reccurence for patients with newly diagnosed intracranial glioblastoma. Neuro-Oncology, 16, 113-122. https://doi.org/10.1093/neuonc/not137
Ellingson, B. M., Abrey, L. E., Nelson, S. J., Kaufmann, T. J., Garcia, J., Chinot, O., Saran, F., Nishikawa, R., Henriksson, R., Mason, W. P., Wick, W., Butowski, N., Ligon, K. L., Gerstner, E. R., Colman, H., De Groot, J., Chang, S., Mellinghoff, I., Young, R. J., … Cloughesy, T. F. (2018). Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro-Oncology, 20, 1240-1250. https://doi.org/10.1093/neuonc/noy053
Ferguson, S. D., Hodges, T. R., Majd, N. K., Alfaro-Munoz, K., Al-Holou, W. N., Suki, D., de Groot, J. F., Fuller, G. N., Xue, L., Li, M., Jacobs, C., Rao, G., Colen, R. R., Xiu, J., Verhaak, R., Spetzler, D., Khasraw, M., Sawaya, R., Long, J. P., & Heimberger, A. B. (2021). A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neuro-Oncology Advances, 3, vdaa146.
Galldiks, N., Dunkl, V., Kracht, L. W., Vollmar, S., Jacobs, A. H., Fink, G. R., & Schroeter, M. (2012). Volumetry of [11 C]-methionine positron emission tomographic uptake as a prognostic marker before treatment of patients with malignant glioma. Molecular Imaging, 11, 516-527. https://doi.org/10.2310/7290.2012.00022
Garcia-Ruiz, A., Naval-Baudin, P., Ligero, M., Pons-Escoda, A., Bruna, J., Plans, G., Calvo, N., Cos, M., Majós, C., & Perez-Lopez, R. (2021). Precise enhancement quantification in post-operative MRI as an indicator of residual tumor impact is associated with survival in patients with glioblastoma. Scientific Reports, 11, 695. https://doi.org/10.1038/s41598-020-79829-3
Grabowski, M. M., Recinos, P. F., Nowacki, A. S., Schroeder, J. L., Angelov, L., Barnett, G. H., & Vogelbaum, M. A. (2014). Residual tumor volume versus extent of resection: Predictors of survival after surgery for glioblastoma. Journal of Neurosurgery, 121, 1115-1123. https://doi.org/10.3171/2014.7.JNS132449
Hirono, S., Hasegawa, Y., Sakaida, T., Uchino, Y., Hatano, K., & Iuchi, T. (2019). Feasibility study of finalizing the extended adjuvant temozolomide based on methionine positron emission tomography (MET-PET) findings in patients with glioblastoma. Scientific Reports, 9, 17794. https://doi.org/10.1038/s41598-019-54398-2
Hirono, S., Ozaki, K., Kobayashi, M., Hara, A., Yamaki, T., Matsutani, T., & Iwadate, Y. (2021). Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: A retrospective, single-center study. Scientific Reports, 11, 14554. https://doi.org/10.1038/s41598-021-93986-z
Hotta, M., Minamimoto, R., & Miwa, K. (2019). 11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: Radiomics approach with random forest classifier. Scientific Reports, 9, 15666. https://doi.org/10.1038/s41598-019-52279-2
Inoue, A., Ohnishi, T., Kohno, S., Ohue, S., Nishikawa, M., Suehiro, S., Matsumoto, S., Ozaki, S., Fukushima, M., Kurata, M., Kitazawa, R., Shigekawa, S., Watanabe, H., & Kunieda, T. (2021). Met-PET uptake index for total tumor resection: Identification of 11C-methionine uptake index as a goal for total tumor resection including infiltrating tumor cells in glioblastoma. Neurosurgical Review, 44, 587-597. https://doi.org/10.1007/s10143-020-01258-7
Ius, T., Sabatino, G., Panciani, P. P., Fontanella, M. M., Rudà, R., Castellano, A., Barbagallo, G. M. V., Belotti, F., Boccaletti, R., Catapano, G., Costantino, G., Della Puppa, A., Di Meco, F., Gagliardi, F., Garbossa, D., Germanò, A. F., Iacoangeli, M., Mortini, P., Olivi, A., … Esposito, V. (2023). Surgical management of Glioma Grade 4: Technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): A systematic review. Journal of Neuro-Oncology, 162, 267-293. https://doi.org/10.1007/s11060-023-04274-x
Kapouleas, I., Alavi, A., Alves, W. M., Gur, R. E., & Weiss, D. W. (1991). Registration of three-dimensional MR and PET images of the human brain without markers. Radiology, 181, 731-739. https://doi.org/10.1148/radiology.181.3.1947089
Karsy, M., Yoon, N., Boettcher, L., Jensen, R., Shah, L., Macdonald, J., & Menacho, S. T. (2018). Surgical treatment of glioblastoma in the elderly: The impact of complications. Journal of Neuro-Oncology, 138, 123-132. https://doi.org/10.1007/s11060-018-2777-9
Kato, T., Shinoda, J., Nakayama, N., Miwa, K., Okumura, A., Yano, H., Yoshimura, S., Maruyama, T., Muragaki, Y., & Iwama, T. (2008). Metabolic assessment of gliomas using 11C-methionine, [18 F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR American Journal of Neuroradiology, 29, 1176-1182. https://doi.org/10.3174/ajnr.A1008
Kawasaki, T., Miwa, K., Shinoda, J., Asano, Y., Takei, H., Ikegame, Y., Yokoyama, K., Yano, H., & Iwama, T. (2019). Dissociation between 11C-methionine-positron emission tomography and gadolinium-enhanced magnetic resonance imaging in longitudinal features of glioblastoma after postoperative radiotherapy. World Neurosurgery, 125, 93-100. https://doi.org/10.1016/j.wneu.2019.01.129
Kracht, L. W., Miletic, H., Busch, S., Jacobs, A. H., Voges, J., Hoevels, M., Klein, J. C., Herholz, K., & Heiss, W. D. (2004). Delineation of brain tumor extent with [11 C]l-methionine positron emission tomography: Local comparison with stereotactic histopathology. Clinical Cancer Research, 10, 7163-7170. https://doi.org/10.1158/1078-0432.CCR-04-0262
Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., Demonte, F., Lang, F. F., Mccutcheon, I. E., Hassenbusch, S. J., Holland, E., Hess, K., Michael, C., Miller, D., & Sawaya, R. (2001). A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. Journal of Neurosurgery, 95, 190-198. https://doi.org/10.3171/jns.2001.95.2.0190
Li, D., Zhang, J., Chi, C., Xiao, X., Wang, J., Lang, L., Ali, I., Niu, G., Zhang, L., Tian, J., Ji, N., Zhu, Z., & Chen, X. (2018). First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using 68Ga-IRDye800CW-BBN. Theranostics, 8, 2508-2520. https://doi.org/10.7150/thno.25599
Lopez-Rivera, V., Dono, A., Lewis, C. T., Chandra, A., Abdelkhaleq, R., Sheth, S. A., Ballester, L. Y., & Esquenazi, Y. (2021). Extent of resection and survival outcomes of geriatric patients with glioblastoma: Is there benefit from aggressive surgery? Clinical Neurology and Neurosurgery, 202, 106474. https://doi.org/10.1016/j.clineuro.2021.106474
Louis, D. N., Perry, A., Reifenberger, G., Von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016). The 2016 World Health Organization classification of tumors of the central nervous system: A summary. Acta Neuropathologica, 131, 803-820. https://doi.org/10.1007/s00401-016-1545-1
Miller, S., Li, P., Schipper, M., Junck, L., Piert, M., Lawrence, T. S., Tsien, C., Cao, Y., & Kim, M. M. (2020). Metabolic tumor volume response assessment using (11)C-methionine positron emission tomography identifies glioblastoma tumor subregions that predict progression better than baseline or anatomic magnetic resonance imaging alone. Advances in Radiation Oncology, 5, 53-61. https://doi.org/10.1016/j.adro.2019.08.004
Miwa, K. (2004). Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: Insight from a PET and MR fusion image study. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1457-1462. https://doi.org/10.1136/jnnp.2003.028480
Molinaro, A. M., Hervey-Jumper, S., Morshed, R. A., Young, J., Han, S. J., Chunduru, P., Zhang, Y., Phillips, J. J., Shai, A., Lafontaine, M., Crane, J., Chandra, A., Flanigan, P., Jahangiri, A., Cioffi, G., Ostrom, Q., Anderson, J. E., Badve, C., Barnholtz-Sloan, J., … Berger, M. S. (2020). Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncology, 6, 495-503. https://doi.org/10.1001/jamaoncol.2019.6143
Pessina, F., Navarria, P., Clerici, E., Bellu, L., Franzini, A., Milani, D., Simonelli, M., Persico, P., Politi, L. S., Casarotti, A., Fernandes, B., Olei, S., Sollini, M., Chiti, A., & Scorsetti, M. (2021). Role of 11C methionine positron emission tomography (11CMETPET) for surgery and radiation therapy planning in newly diagnosed glioblastoma patients enrolled into a phase II clinical study. Journal of Clinical Medicine, 10, 2313. https://doi.org/10.3390/jcm10112313
Pirotte, B., Goldman, S., Dewitte, O., Massager, N., Wikler, D., Lefranc, F., Ben Taib, N. O., Rorive, S., David, P., Brotchi, J., & Levivier, M. (2006). Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: A report of 103 consecutive procedures. Journal of Neurosurgery, 104, 238-253. https://doi.org/10.3171/jns.2006.104.2.238
Pirotte, B. J. M., Levivier, M., Goldman, S., Massager, N., Wikler, D., Dewitte, O., Bruneau, M., Rorive, S., David, P., & Brotchi, J. (2009). Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: A survival analysis in 66 consecutive patients. Neurosurgery, 64, 471-481. https://doi.org/10.1227/01.NEU.0000338949.94496.85
Royston, P., Altman, D. G., & Sauerbrei, W. (2006). Dichotomizing continuous predictors in multiple regression: A bad idea. Statistics in Medicine, 25, 127-141. https://doi.org/10.1002/sim.2331
Sanai, N., Polley, M. Y., Mcdermott, M. W., Parsa, A. T., & Berger, M. S. (2011). An extent of resection threshold for newly diagnosed glioblastomas. Journal of Neurosurgery, 115, 3-8. https://doi.org/10.3171/2011.2.JNS10998
Shah, A. H., Mahavadi, A., Di, L., Sanjurjo, A., Eichberg, D. G., Borowy, V., Figueroa, J., Luther, E., De La Fuente, M. I., Semonche, A., Ivan, M. E., & Komotar, R. J. (2020). Survival benefit of lobectomy for glioblastoma: Moving towards radical supramaximal resection. Journal of Neuro-Oncology, 148, 501-508. https://doi.org/10.1007/s11060-020-03541-5
Shen, B., Zhang, Z., Shi, X., Cao, C., Zhang, Z., Hu, Z., Ji, N., & Tian, J. (2021). Real-time intraoperative glioma diagnosis using fluorescence imaging and deep convolutional neural networks. European Journal of Nuclear Medicine and Molecular Imaging, 48, 3482-3492.
Shi, X., Zhang, Z., Zhang, Z., Cao, C., Cheng, Z., Hu, Z., Tian, J., & Ji, N. (2022). Near-infrared window II fluorescence image-guided surgery of high-grade gliomas prolongs the progression-free survival of patients. IEEE Transactions on Bio-Medical Engineering, 69, 1889-1900.
Singhal, T., Narayanan, T. K., Jain, V., Mukherjee, J., & Mantil, J. (2008). 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Molecular Imaging and Biology, 10, 1-18. https://doi.org/10.1007/s11307-007-0115-2
Stupp, R., Mason, W. P., Van Den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R. C., Ludwin, S. K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J. G., Eisenhauer, E., & Mirimanoff, R. O. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 352, 987-996. https://doi.org/10.1056/NEJMoa043330
Stupp, R., Taillibert, S., Kanner, A., Read, W., Steinberg, D. M., Lhermitte, B., Toms, S., Idbaih, A., Ahluwalia, M. S., Fink, K., Di Meco, F., Lieberman, F., Zhu, J. J., Stragliotto, G., Tran, D. D., Brem, S., Hottinger, A. F., Kirson, E. D., Lavy-Shahaf, G., … Ram, Z. (2017). Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial. Jama, 318, 2306-2316. https://doi.org/10.1001/jama.2017.18718
Voisin, M. R., Sasikumar, S., & Zadeh, G. (2021). Predictors of survival in elderly patients undergoing surgery for glioblastoma. Neuro-Oncology Advances, 3, vdab083.
Wang, Y., Rapalino, O., Heidari, P., Loeffler, J., Shih, H. A., Oh, K., & Mahmood, U. (2018). C11 methionine PET (MET-PET) imaging of glioblastoma for detecting postoperative residual disease and response to chemoradiation therapy. International Journal of Radiation and Oncology in Biology and Physics, 102, 1024-1028. https://doi.org/10.1016/j.ijrobp.2018.06.011
Youngblood, M. W., Stupp, R., & Sonabend, A. M. (2021). Role of resection in glioblastoma management. Neurosurgery Clinics of North America, 32, 9-22. https://doi.org/10.1016/j.nec.2020.08.002